Platelet: transporter of vascular endothelial growth factor.
about
Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?Platelet effects on ovarian cancerPlatelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor releaseQuercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cellsArachidonic acid and Docosahexanoic acid enhance platelet formation from human apheresis-derived CD34+ cells.Chronic cocaine induces HIF-VEGF pathway activation along with angiogenesis in the brain.Isolation and proteomic analysis of platelets by SELDI-TOF MS.Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarkerHuman umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo.Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor.Prognostic significance of preoperative platelet count in patients with gallbladder cancer.Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.Involvement of vascular endothelial growth factor -460 C/T, +405 G/C and +936 C/T polymorphisms in the development of endometriosis.Targeting the endothelin axis with atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinomaAnti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapyPlatelets at the interface of thrombosis, inflammation, and cancer.Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans.Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor levelSerum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.High-risk early breast cancer in patients under 40 years of age: Improved clinical outcome with total estrogen blockade and tailored chemotherapy.Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension.Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor.Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.Vascular endothelial growth factor and breast cancer risk.The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers.Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer.VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe traumaThe prothrombotic activity of cancer cells in the circulationPlatelet proteome and tumor dormancy: can platelets content serve as predictive biomarkers for exit of tumors from dormancy?Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.Cancer and Thrombosis: The Platelet Perspective.The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology.
P2860
Q24804008-FF1DAAAC-C24A-4CE9-BA73-5442B88735CFQ26829401-927DA04E-2ADA-4FDB-A080-FE3F2C871854Q28365226-7E14449C-34EB-4503-9394-4E2C75719CE8Q28480617-C00FEB9D-2FEE-49A2-91DB-99AF7B5992A9Q33440774-88AA6E46-7BDF-4273-B59E-40C6417094F8Q33610969-4BED3D4B-4B11-4DB0-AC96-71B9EF60A1ADQ33803553-A98A3C12-31DB-49A3-8F63-CE070AA31F86Q33920807-CA451C45-0034-485E-ABD7-1DAA727178AAQ34132889-FD865421-212D-4EDA-B355-0160CFD6301AQ35009777-11ECB47A-7778-429A-85D8-5BF7730E4BBBQ35354678-E02AABE7-40D1-4D1A-AE9F-AD6D43C2E2E0Q35545895-EEDEC54F-5FE0-4226-A117-9E0EE92155E8Q35567661-11965A67-99DF-494D-98B5-F7E40DADD9D1Q35586682-35589BDD-468C-420B-9D4C-2262D466F9B1Q35662472-2C0624E8-7E98-4D99-9EF3-7DA68A275CA6Q35681948-5F8F7044-B8CB-487D-9F84-65816F71236CQ35834584-C428EE57-FD57-4E7A-8389-5B8C466F34B5Q35904932-727096DB-9ABB-44DE-962E-8993B2996072Q35934127-AF6FCB1C-0FC4-4283-97A9-20EBCEE97F87Q35940940-1571D337-91B4-4E45-9B9C-1B031080A8A4Q36065624-803937E1-B554-4FCB-89EE-DAFC2ABD9D18Q36185056-C4E9632A-80DF-457D-B794-8F128A60AF52Q36244136-85E27291-6538-4A87-A90A-47D4DDC34FD4Q36415546-0DA3CC4D-B2B3-4BBB-81BA-8D6CD3140997Q36464882-BABA08A8-F2E8-49F0-B211-07B0C9D13EBCQ36611325-3B2CDB9D-2C8E-42A6-974D-62F0D0E59E88Q36617784-07D9E4E5-B0A3-4B7E-AC0B-4A52669916C9Q36619082-2402CB03-F8D3-473A-A96C-B28E3E75390BQ36624140-536786F9-FBC0-4CE5-A18D-578ADDCD70B7Q36643769-1CA1263F-FF14-4C5A-890A-4BF2DCC46CEEQ36644569-4B1B292D-E3B8-4426-9CD5-DFA6A64CF543Q36646431-7DCC86FB-E106-4DA3-B6C5-6EC73427B6CFQ36868343-0D7BA125-A1C6-417B-9FC2-FBB16EF9C4BFQ36925848-FD96BDB7-2B4F-4CFC-9A88-EF9E2D8BA735Q37088087-FA882B7C-B462-4F01-9869-C45E0BAAD085Q37328356-D37B2734-7860-4424-8534-72C37C6EC7ACQ37479698-B8CE0691-F505-4C1E-B627-C1219D3CD5FDQ37558436-6779A156-734A-4D7B-9D5D-894AA12832CBQ37636781-2698A060-09BA-4627-8970-6A69BE2E8C61Q38128286-3DCB2B15-F6CA-4BDA-BCB2-AB25F6475725
P2860
Platelet: transporter of vascular endothelial growth factor.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Platelet: transporter of vascular endothelial growth factor.
@ast
Platelet: transporter of vascular endothelial growth factor.
@en
type
label
Platelet: transporter of vascular endothelial growth factor.
@ast
Platelet: transporter of vascular endothelial growth factor.
@en
prefLabel
Platelet: transporter of vascular endothelial growth factor.
@ast
Platelet: transporter of vascular endothelial growth factor.
@en
P2093
P1476
Platelet: transporter of vascular endothelial growth factor.
@en
P2093
Broxterman HJ
Luykx-de Bakker S
Verheul HM
P304
P407
P433
P577
1997-12-01T00:00:00Z